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Background: Nonspecific interstitial pneumonia (NSIP) is characterized by the interstitial infil-
tration T lymphocytes (TLs). Bronchoalveolar lavage fluid (BALF) has been used to analyze the
inflammatory cells infiltrating in lung. The controversy about whether the BALF cellular profile
reflects T lymphocytes in lung tissue still persists. Some studies found a positive correlation of
cell composition between BALF and lung tissue, but others gave opposite conclusion.
Objective: To investigate CD4þ and CD8þ T lymphocytes distribution in lung tissue of NSIP and
the relationship with T lymphocytes in bronchoalveolar lavage.
Methods: Thirty-seven patients diagnosed as NSIP were included. The pathological and BALF
date were reviewed. The characteristics of TLs infiltration in different lung regions were inves-
tigated.stitial pneumonia; UIP, usual interstitial pneumonia; BALF, bronchoalveolar lavage fluid; IPF, idio-
itial lung disease; TLs, T lymphocytes; ESR, erythrocyte sedimentation rate; TLC, total lung capacity;
on monoxide; SSc, systemic scleroderma; pSS, primary sjo¨gren’s syndrome; PM, polymyositis; HRCT,
.
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CD4þ and CD8þ T lymphocytes in lung tissue of NSIP 121Results: The study included 28 women. The median age was 48 years. In lung tissue, CD4þ and
CD8þ lymphocytes (counts/0.1mm2) were separately accounted in lymphoid follicle region
(156.51  90.70 vs 85.30  43.75), small blood vessel region (66.58  31.99 vs
58.43  30.24), interstitial region (37.60  19.40 vs 47.12  33.42) and small airway
region (26.59  17.04 vs 40.18  34.02). CD4þ/CD8þ ratios in lymphoid follicle and small
vessel > 1, in interstitium and small airway <1. The number of CD8þ lymphocytes in BALF
was correlated with CD8þ lymphocytes around small airway (r Z 0.360, p Z 0.029) and in
interstitial region (rZ 0.451, p Z 0.005). CD4þ/CD8þ ratio in BALF was correlated with that
in small airway region (r Z 0.437, p Z 0.007) and interstitial region (r Z 0.468, p Z 0.003).
Conclusions: In NSIP, T lymphocytes were distributed in different regions of lung tissue. The
CD8þ T lymphocytes and CD4þ/CD8þ ratio in BALF reflect those in interstitium regions and
around small airway of the lung.
ª 2012 Elsevier Ltd. All rights reserved.Introduction
Nonspecific interstitial pneumonia (NSIP) is an injury
pattern that can be found in many clinical settings. It can
be associated with many conditions such as connective
tissue disease, drug exposure and hypersensitivity pneu-
monia.1 This histologic pattern is characterized by infiltra-
tion of inflammatory cells in the interstitium, consisting of
lymphocytes and plasma cells. Infiltrating lymphocytes,
predominantly CD4þ T lymphocytes, with an elevated
CD4þ/CD8þ T cell ratio were found in NSIP patients.2,3 The
distribution of T lymphocyte subsets reveals that CD4þ TLs
are observed mainly inside and around lymphoid follicles
and in the thick fibrotic wall of reconstructed alveoli, while
CD8þ TLs are diffusely distributed, especially in relatively
thin alveoli.4
Bronchoalveolar lavage fluid (BALF) has been used to
analyze the inflammatory cells infiltrated in alveolar wall
and around small airways.5-7 When BAL is used in conjunc-
tion with comprehensive clinical information and HRCT,
BAL nucleated immune cell patterns can frequently provide
useful information for diagnostic evaluation and lessen the
need to proceed to more invasive procedures, such as
surgical lung biopsy.8
However, controversy always exists about whether the
BALF cellular profile reflects cell composition in lung tissue.
Some studies6,9e14 have shown a positive correlation of
composition between BALF and the lung tissue and BALF
findings may consider as a predictor of progression or
treatment response. Whereas other studies have given
an15e18 opposite conclusion, BAL fluid components, cells in
particular, are not correlated well with activity of disease
nor for monitoring disease progress or response to
treatment.19
Is the distribution form of lymphocyte subsets in the lung
tissue obtained by surgical lung biopsy different from that
in BALF? Why are the studies about the correlation of
T-lymphocyte subsets between lung tissue and BALF
controversial?
In order to better understand the underlying reasons of
these inconsistencies, this study was performed to evaluate
the distribution features of T lymphocyte subsets in NSIP
lung tissue and the relationship of lymphocyte subsets
distribution between the lung tissue and BALF.Material and methods
Subjects
Between April 2003 and August 2010, ninety-six patients
from Peking Union Medical College Hospital (PUMCH) were
diagnosed histopathologically as NSIP by surgical lung
biopsy. Thirty-seven of these ninety-six NSIP patients, who
had the results of lymphocytes analysis of BALF, were
enrolled in this study. None of these Thirty-seven NSIP
patients had the history of occupational inhalation of dust
or virulent drug exposure. Hypersensitivity pneumonitis was
excluded according to patient’s exposure history, serum
antibodies tests to the offending antigen.20,21 None of them
were treated with corticosteroid and immunosuppressive at
the time of bronchoscope examination and surgical lung
biopsy. BALF and TBLB were done at first and after the
infectious disease was excluded, surgical lung biopsy was
performed within 2 weeks. Their clinical features, radio-
logical images, BALF lymphocyte subsets and pathological
findings were reviewed and analyzed retrospectively.
Histology of lung tissue
Surgical lung biopsy specimens were reviewed by two senior
pathologists independently and the consensus was
reached for the histologic pattern. Thirty-seven cases were
subclassified according to criteria proposed by Katzenstein
and Fiorelli22 as cellular, mixed and fibrotic pattern
(Supplement materials Table 1). Small airways were
defined as those with the internal diameter less than 2 mm
and without cartilage.23 Small blood vessels were defined as
those with the internal diameter no more than 100 mm.32
Immunohistochemistry of lung tissue
Lung biopsy specimens were fixed in 10% neutral buffered
formalin solution, cut into slices, embedded in paraffin,
and sectioned at 4 mm paraffin thickness for histologic
evaluation. Paraffin sections were immunohistochemically
stained with anti-CD4 antibody (clone SP35, Zeta), and
anti-CD8 antibody (clone EP1150, Zeta), according to the
labeled StreptavidineBiotin Complex method. The sections
122 L. Qin et al.were deparaffinized and rehydrated with Tris-Buffered
Saline (TBS: 0.005 M Tris, 0.15 M NaCl), pH Z 7.6 for
10 min. Endogenous peroxidase was blocked with 3%
hydrogen peroxide for 5 min. Then they were washed in TBS
and incubated with primary antibodies at the appropriate
dilutions for 1 h CD4 and CD8 staining was performed on the
same tissue sections.
The number of positively stained cells with dark brown
staining were analyzed by the NanoZoomer 2.0-RS slide
scanning system (Hamamatsu Photonics KK; Japan) and
Anymicro DSS Pro image analysis system (YuTianShiJiWeiYe
INC; Beijing, China). Four microscopic regions (follicless,
small blood vessels, interstitium and small airways) were
analyzed. Each biopsy slide contains 4 microscopic regions
of above mentioned. CD4 and CD8 images were obtained in
the same region of the slide (Fig. 1). At least 6 high-power
fields (magnification  20; analysis area, approximately
0.162 mm2) were randomly selected for each region and
used for positive cell counting.
Analysis of lymphocyte subsets from BALF
Thirty-seven patients with NSIP underwent bronchoscope
examination with electric video bronchoscope (Olympus
Co, Tokyo, Japan) wedged into a segmental bronchus of the
right middle lobe or lingula of the left upper lobe. One
hundred milliliters of sterilized saline were injected gently
by a syringe through the bronchoscope and collected by
deep inspiration according to the guidelines for measure-
ment of acellular components and standardization of
BAL.7,24 The BALF was pooled, measured in volume, andFigure 1 Distribution of T lymphocytes in different regions of lu
follicle, small blood vessel, interstitial and around small airways rthen filtered through nylon sterile gauze to remove mucus.
The BALF was centrifuged at 400 g 4 C for 10 min to
separate cells from fluids. The total cell count was evalu-
ated on an aliquot of the pooled fluid using a Neubauer
counting chamber. The cells were washed twice with
phosphate-buffered saline solution and differential cell
counts were performed with May-Grunwald-Giemsa stain-
ing. To evaluate the cell subsets, lymphocytes were stained
with anti-CD3, anti-CD4 and anti-CD8 monoclonal anti-
bodies coupled to fluorescein isothiocyanate, and cellular
fluorescence was measured with a FACS calibur flow
cytometer.
Treatment and follow up
At the initiation of treatment, all patients received a course
of oral prednisolone, starting at 0.5 mg/kg/d for one month
which was then tapered every 3 weeks to 5e7.5 mg/d. The
total length of treatment was 12e18 months. Cyclophos-
phamide was administered at the beginning with steroid
therapy at the dose of 100 mg/d given orally for 18 months
in patients diagnosed as CTD-NSIP. Patients underwent
routine examinations every 3 month after surgical lung
biopsy, and then once a year in the following years in
Interstitial Lung Disease Clinic of PUMCH.
Statistical analysis
All expressed values are mean  SD. T test was used for
analysis of normal distribution samples. Wilcoxon Test and
KruskaleWallis Test were used to compare two or moreng tissue: CD4þ and CD8 þ TLs decreased gradually in order of
egions.
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coefficients were calculated using the Spearman rank
method. Probability value was obtained from 2-sided tests,
with a statistical significance of p < 0.05. SPSS 15.0 (SPSS
for Windows, version 15.0 [SPSS Inc., Chicago, Illinois, USA])
was used for statistical analysis.
This study was approved by the Peking Union Medical
College Hospital Institutional Review Board.
Patients who did not authorize the use of their medical
records for research were excluded from this study.Results
Clinical features and laboratory findings
The mean age of 37 patients was 48.9  10.5 years (range
from 23 to 68 years) and 28/37 (75.7%) patients were
women. There were 31/37 (83.8%) nonsmokers, 4/37
(10.8%) ex-smokers and 2/37 (5.4%) current smokers. Five
NSIP patients were secondary to CTD, including 3 primary
sjo¨gren’s syndrome, 1 systemic scleroderma, and 1 poly-
myositis. The clinical features and laboratory results of 37
patients were summarized in Table 1. The duration ofTable 1 Clinical features and laboratory findings.
Characteristics NSIP (n Z 37)
Symptoms
Dyspnea 30/37 (81.08%)
Cough 24/37 (64.86%)
Chest pain 2/37 (5.41%)
Dry eyes or dry mouth 2/37 (5.41%)
Fever 4/37 (10.81%)
Arthralgia 6/37 (16.21%)
Rash 2/37 (5.41%)
Raynaud’s phenomenon 2/37 (5.41%)
Weight loss 1/37 (2.70%)
Signs
Crackles 28/37 (75.68%)
Clubbing 20/37 (54.05%)
Laboratory tests
ESR, mm/h 20.54  21.55
PaO2, mmHg 76.82  10.75
PCO2, mmHg 37.21  4.99
Antinuclear antibody 10/37 (27.02%)
Anti-SSA antibody 3/37 (8.11%)
Anti-neutrophil cytoplasmic antibody 2/37 (5.41%)
Anti-Jo-1 antibody 1/37 (2.70%)
Anti-Scl-70 antibody 1/37 (2.70%)
TLC, % predicteda 77.06  11.72
DLCO, % predicteda 55.53  16.16
Chest CT findings at the time of biopsy
Ground glass opacity 21/37 (56.76%)
Patch 26/37 (70.27%)
Irregular reticular opacity 23/37 (62.16%)
Traction bronchiectasis 14/37 (37.84%)
Pleural thickness 5/37 (13.51%)
a 31 patients completed pulmonary function test.respiratory symptoms from onset to lung biopsy ranged
from 0.8 to 72 months (median 6 months). All the patients
were followed up for a median period of 40 months (range
from 15 to 109 months). During follow-up, 4/37 (10.8%),
including 2 patients with mixed NSIP and 2 with fibrotic NSIP
died of progression of the disease.
T lymphocyte subsets distribution in different
regions of lung tissue
Distribution of CD4þ T lymphocytes was shown in Fig. 1.
The counts/0.1 mm2 of CD4þ TLs The CD4þ TLs decreased
gradually in order of follicle, small blood vessel, interstitial
and small airway regions (Supplement materials Table 2).
The differences of cell counts between every two different
regions were statistically significant (Fig. 2A, all p < 0.001).
Distribution of CD8þ T lymphocytes was shown in Fig. 1.
It had similar trend to the distribution of CD4þ T lympho-
cytes (Supplement materials Table 2). Lymphocytes in
follicles were much more than those in each of the other
three regions (Fig. 2B, all p < 0.001).
The distribution of CD4D and CD8D T lymphocytes
in different pathologic patterns of NSIP
According to pathologic criteria of NSIP, 15 cellular NSIPs,
19 mixed NSIPs and 3 fibrotic NSIPs were diagnosed and
analyzed. The patients were divided into two groups:
cellular and mixed/fibrotic groups (only 3 patients in
fibrotic group, so we combined mixed and fibrotic NSIPs in
one group). Comparing with mixed/fibrotic NSIPs, we found
that CD4þ TLs infiltrating around small blood vessel and in
interstitial region were more prominent in cellular NSIPs.
CD8þ TLs infiltrating in lung tissue of cellular NSIPs were
also more than those in mixed/fibrosis NSIPs in each of the
studied regions (Table 2). Since CD4þ TLs decreased more
prominent than CD8þ TLs in order of follicle, small blood
vessel, interstitial and small airway regions, CD4þ/CD8þ
ratios in cellular pattern decreased more sharply than those
in mixed/fibrotic pattern, with the ratio <1 in cellular
pattern and >1 in mixed/fibrotic pattern in the regions of
interstitial and small airway. However, the differences of
CD4þ/CD8þ ratios between cellular group and mixed/
fibrotic group were not statistically significant in any of the
four regions (Table 2).
Relationship between lung tissue and BALF for
CD4D and CD8DT lymphocytes and CD4D/CD8D
ratio
The relationship between T lymphocyte subsets in BALF and
those infiltrating in lymphoid follicles, around small blood
vessels, interstitial region or around small airways were
analyzed (Supplement materials Table 2) respectively.
CD8þ TLs in BALF were significantly correlated with those
around small airways (Fig. 3A) and with those in interstitial
region (Fig. 3B), but not with those around small blood
vessels and in lymphoid follicles. CD4þ TLs in BALF were
not correlated with those in any of the four study regions.
The relationship of CD4þ/CD8þ ratio between BALF and
each of the four study regions were analyzed (Supplement
Figure 2 (A) Distribution of CD4þ T lymphocytes in different regions of lung tissue. CD4þ cell counts between every two
different regions were statistically significant (p < 0.001). (B) Distribution of CD8 þ T lymphocytes in different regions of lung
tissue. CD8þ cell in follicles were much more than those in each of the other three regions (p < 0.001).
124 L. Qin et al.materials Table 2). CD4þ/CD8þ ratio in BALF was corre-
lated with those in small airway (Fig. 3C) and interstitial
regions (Fig. 3D), but not with those around small blood
vessels and in lymphoid follicles.Discussion
Distribution features of T lymphocyte subsets in
NSIP lung tissue
In our study, we found that CD4þ T lymphocytes were
mainly infiltrated inside lymphoid follicle and perivascular
region. In contrast, CD8þ T lymphocytes were diffusely
distributed in lung tissue with the highest quantity in
lymphoid follicle and similar distribution among inter-
stitium, small vessel and small airway regions. The
different distribution patterns of CD4þ and CD8þ TLs sug-
gested that they might play different roles in the process ofTable 2 Comparison of T lymphocyte subsets and CD4þ/CD8þ
Cellular pattern (n Z
CD4þ T lymphocytes of tissue (counts/0.1 mm2)
Lymphoid follicle region 168.64  93.14
Small blood vessel region 86.82  33.70
Interstitial region 47.76  20.75
Small airway region 30.25  17.97
CD4þ T lymphocytes of BALF (106/L) 0.79  0.75
CD8þ T lymphocytes of tissue (counts/0.1 mm2)
Lymphoid follicle region 109.67  58.09
Small blood vessel region 66.93  36.72
Interstitial region 61.98  44.81
Small airway region 57.22  44.87
CD8þ T lymphocytes of BALF (106/L) 3.63  4.23
CD4þ/CD8þ ratio of tissue
Lymphoid follicle region 1.69  0.70
Small blood vessel region 1.43  0.48
Interstitial region 0.89  0.91
Small airway region 0.67  0.50
CD4þ/CD8þratio of BALF 0.57  0.15the lung injury.25,26 CD4þ T lymphocytes, as T helper cells,
might express different chemokine receptors which could
facilitate themselves move to the various tissues, espe-
cially to lymphoid follicles and small vessels. CD8þ T
lymphocytes, as the effective cells, can directly combine
with the class I antigens and remove pathogen or foreign
body. It was more convenient and important for CD8þ T
lymphocytes distributing diffusely in the lung tissue to keep
the balance of immune defence function.27,28
Variable CD4D/CD8D ratios in lung tissue of NSIP
Shimizu29 found that CD4þ TLs were the main inflammatory
cells in ILD associated with CTD (CTD-ILD), while CD8þ TLs,
in IPF. CD4þ/CD8 ratio of CTD-ILD was lower than that of
IPF.29,30 According to CD4þ/CD8þ ratio in the lung
tissue, Fireman32 divided NSIP patients into two
categories, patients with high CD4þ/CD8þ ratio (>1) and
with low CD4þ/CD8þ ratio (<1). He considered that theratio between BALF and different NSIP pathological patterns.
15) Mixed/fibrotic pattern (n Z 22) p value
148.24  90.21 0.404
52.77  22.48 0.001
30.67  15.29 0.009
24.09  16.33 0.205
0.97  0.96 0.720
68.68  17.82 0.008
35.82  16.05 0.001
36.98  17.61 0.044
28.56  17.12 0.031
1.07  1.23 0.037
2.36  1.67 0.322
1.70  0.94 0.902
1.04  0.95 0.926
1.14  1.04 0.353
1.12  1.30 0.020
Figure 3 T lymphocyte profile relationship between tissue and BALF disclose positive relations were found between CD8þ TLs in
small airway and those in BALF (A), interstitial CD8þ TLs and those in BALF (B), CD4þ/CD8þ ratios in small airway and that in BALF
(C), interstitial CD4þ/CD8þ ratios and CD4þ/CD8þ ratios of BALF (D), respectively.
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and at the early stage of the disease, while the low CD4þ/
CD8þ ratio was associated with fibrotic pattern and at the
late stage of the lung injury. Our results showed that even
in the same patient with cellular NSIP pattern, CD4þ/CD8þ
ratio was quite different in different regions. The CD4þ/
CD8þ ratios in lymphoid follicle and small blood vessel
regions were higher (>1) than those in interstitial and small
airway regions (<1). These results might explain the
different descriptions about CD4þ/CD8þ ratio in the lung
tissue of NISP in previous studies. We believe that insight
into the features of T lymphocyte subsets distribution in
different anatomical regions would help us understand the
inflammatory process of NSIP.
CD4D/CD8D ratio of BALF predicts the
pathological pattern of NSIP
Over the past three decades, the technique of bron-
choalveolar lavage has yielded important information in
staging the pathological pattern of NSIP and predicting
response to therapy. Nagai’s work18 about the relationship
between lymphocyte subsets in BALF and clinical outcomes
showed that low CD4þ/CD8þ ratio of BALF in cellular NSIP
correlated with better prognosis, while patients with
fibrotic NSIP and IPF had high CD4þ/CD8þ ratio and worse
prognosis. Yamadori found that in NSIP patients with clini-
cally evident pulmonary fibrosis, CD8þ TLs counts in BALF
were reduced sharply.9 In present study, we analyzed Tlymphocyte subsets in cellular and mixed/fibrostic patterns
and compared the CD4þ/CD8þ ratio in the various regions
of lung tissue among the different pathological patterns.
Our results showed that the changes of CD4þ/CD8þ ratio in
the lung tissue could be reflected through the CD4þ/CD8þ
ratio in BALF, which was correlated to the ratio in inter-
stitial or small airway regions. Our observations that in NSIP
patients the T lymphocyte subsets (CD8þ TLs) as well as the
CD4þ/CD8þ ratio recovered by BAL were related to those
in lung tissue indicated that by the use of a far less invasive
technique of BAL, reliable information could be derived to
predict the pathological patterns of NSIP.8,31
We recognize that our study is limited by its retrospec-
tive analysis. B lymphocyte and other inflammatory cells
are not investigated in this study. The second limitation was
that the BALF was performed in middle lobe or lingula of
the left upper lobe according ERS guideline for interstitial
lung disease and the surgical biopsy in our study was per-
formed in lower lobe, this may lead mismatch in T
lymphocyte subsets between BALF and lung tissue.
Nevertheless, to the best of our knowledge, no studies
have evaluated T lymphocyte subsets in both surgically
obtained lung tissue samples in different anatomical
regions and BALF by quantitative immunohistochemistry
and flow cytometry, respectively, in NSIP patients. We
believe that the valid data in this study may reveal the
pathogenic characteristics of NSIP.
Conclusion: In NSIP patients, T lymphocytes were
distributed in different regions of lung tissues. CD8þ TLs
126 L. Qin et al.and CD4þ/CD8þ ratios in BALF may reflect those in inter-
stitial regions and around small airways.
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